"etanercept" meaning in All languages combined

See etanercept on Wiktionary

Noun [English]

IPA: /ɪˈtæn.ɚˌsɛpt/ [General-American]
Etymology: From eta- (of unknown origin) + -nercept (“TNF receptor ligand”). Etymology templates: {{af|en|eta-|-nercept|qq1=of unknown origin|t2=TNF receptor ligand}} eta- (of unknown origin) + -nercept (“TNF receptor ligand”) Head templates: {{en-noun|-}} etanercept (uncountable)
  1. (pharmacology) A protein drug that binds to and blocks the action of tumor necrosis factor and is administered by injection to treat various inflammatory diseases (such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis). It is a dimeric protein consisting of the ligand-binding portion of a human receptor for tumor necrosis factor linked to the basal, heavy chain, portion of IgG which determines the immune response to bound antigen. It is produced by recombinant DNA technology using hamster ovary cells and is marketed under the trademark Enbrel. Wikipedia link: etanercept Tags: uncountable Categories (topical): Pharmaceutical drugs

Alternative forms

Download JSON data for etanercept meaning in All languages combined (3.1kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "eta-",
        "3": "-nercept",
        "qq1": "of unknown origin",
        "t2": "TNF receptor ligand"
      },
      "expansion": "eta- (of unknown origin) + -nercept (“TNF receptor ligand”)",
      "name": "af"
    }
  ],
  "etymology_text": "From eta- (of unknown origin) + -nercept (“TNF receptor ligand”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "etanercept (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with eta-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -nercept",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A protein drug that binds to and blocks the action of tumor necrosis factor and is administered by injection to treat various inflammatory diseases (such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis). It is a dimeric protein consisting of the ligand-binding portion of a human receptor for tumor necrosis factor linked to the basal, heavy chain, portion of IgG which determines the immune response to bound antigen. It is produced by recombinant DNA technology using hamster ovary cells and is marketed under the trademark Enbrel."
      ],
      "id": "en-etanercept-en-noun-i7uzOgom",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "protein",
          "protein"
        ],
        [
          "tumor necrosis factor",
          "tumor necrosis factor"
        ],
        [
          "injection",
          "injection"
        ],
        [
          "inflammatory",
          "inflammatory"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "psoriatic",
          "psoriatic"
        ],
        [
          "arthritis",
          "arthritis"
        ],
        [
          "ankylosing spondylitis",
          "ankylosing spondylitis"
        ],
        [
          "dimeric",
          "dimeric"
        ],
        [
          "ligand",
          "ligand"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "basal",
          "basal"
        ],
        [
          "IgG",
          "IgG"
        ],
        [
          "immune",
          "immune"
        ],
        [
          "antigen",
          "antigen"
        ],
        [
          "recombinant DNA",
          "recombinant DNA"
        ],
        [
          "hamster",
          "hamster"
        ],
        [
          "ovary",
          "ovary"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A protein drug that binds to and blocks the action of tumor necrosis factor and is administered by injection to treat various inflammatory diseases (such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis). It is a dimeric protein consisting of the ligand-binding portion of a human receptor for tumor necrosis factor linked to the basal, heavy chain, portion of IgG which determines the immune response to bound antigen. It is produced by recombinant DNA technology using hamster ovary cells and is marketed under the trademark Enbrel."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "etanercept"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ɪˈtæn.ɚˌsɛpt/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "etanercept"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "eta-",
        "3": "-nercept",
        "qq1": "of unknown origin",
        "t2": "TNF receptor ligand"
      },
      "expansion": "eta- (of unknown origin) + -nercept (“TNF receptor ligand”)",
      "name": "af"
    }
  ],
  "etymology_text": "From eta- (of unknown origin) + -nercept (“TNF receptor ligand”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "etanercept (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 4-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with eta-",
        "English terms suffixed with -nercept",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A protein drug that binds to and blocks the action of tumor necrosis factor and is administered by injection to treat various inflammatory diseases (such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis). It is a dimeric protein consisting of the ligand-binding portion of a human receptor for tumor necrosis factor linked to the basal, heavy chain, portion of IgG which determines the immune response to bound antigen. It is produced by recombinant DNA technology using hamster ovary cells and is marketed under the trademark Enbrel."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "protein",
          "protein"
        ],
        [
          "tumor necrosis factor",
          "tumor necrosis factor"
        ],
        [
          "injection",
          "injection"
        ],
        [
          "inflammatory",
          "inflammatory"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "psoriatic",
          "psoriatic"
        ],
        [
          "arthritis",
          "arthritis"
        ],
        [
          "ankylosing spondylitis",
          "ankylosing spondylitis"
        ],
        [
          "dimeric",
          "dimeric"
        ],
        [
          "ligand",
          "ligand"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "basal",
          "basal"
        ],
        [
          "IgG",
          "IgG"
        ],
        [
          "immune",
          "immune"
        ],
        [
          "antigen",
          "antigen"
        ],
        [
          "recombinant DNA",
          "recombinant DNA"
        ],
        [
          "hamster",
          "hamster"
        ],
        [
          "ovary",
          "ovary"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A protein drug that binds to and blocks the action of tumor necrosis factor and is administered by injection to treat various inflammatory diseases (such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis). It is a dimeric protein consisting of the ligand-binding portion of a human receptor for tumor necrosis factor linked to the basal, heavy chain, portion of IgG which determines the immune response to bound antigen. It is produced by recombinant DNA technology using hamster ovary cells and is marketed under the trademark Enbrel."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "etanercept"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ɪˈtæn.ɚˌsɛpt/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "etanercept"
}

This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-05-25 from the enwiktionary dump dated 2024-05-02 using wiktextract (bb24e0f and c7ea76d). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.